1-4 of 4
Bettina Wingelhofer
Close
Sort by
Journal Articles

NK-2 Homeobox Transcription Factor NKX2-3 Confers Differentiation Block in NPM1-Mutated in Acute Myeloid Leukaemia

John A Chadwick, Bettina Wingelhofer, Tim CP Somervaille
Journal: Blood
Blood (2023) 142 (Supplement 1): 2759.
https://doi.org/10.1182/blood-2023-182990
Published: 2023
Journal Articles

Prognostic and Therapeutic Implications of TP53 expression in Chronic Myelomonocytic Leukaemia: Results of a Multicentre Study

Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Fabio Amaral, Chi-Yuan Yao, Joanna Storer, Luciano Nicosia, Bettina Wingelhofer, Hsin-An Hou, Andres Jerez, Wen-Chien Chou, Kiran Batta, Hwei-Fang Tien, Daniel H Wiseman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3213.
https://doi.org/10.1182/blood-2023-180034
Published: 2023
Journal Articles

Therapeutic Targeting of EP300/CBP By Bromodomain Inhibition in Acute Myeloid Leukemia

Luciano Nicosia, Gary J Spencer, Nigel Brooks, Fabio Amaral, Naseer Basma, John Chadwick, Bradley Revell, Bettina Wingelhofer, Alba Maiques-Diaz, Filippo Ciceri, Daniel H Wiseman, Neil A Pegg, William West, Tomasz Knurowski, Kris Frese, Karen Clegg, Victoria Louise Campbell, Mhairi Copland, Emma Searle, Tim C.P Somervaille
Journal: Blood
Blood (2022) 140 (Supplement 1): 8774–8775.
https://doi.org/10.1182/blood-2022-166260
Published: 2022
Journal Articles

Genome-Wide CRISPR-Cas9 Screen Identifies Sensitizers to LSD1 Inhibition in MLL-Translocated Human AML Cells

Gauri Deb, MS, PhD, Bettina Wingelhofer, PhD, Emma Williams, PhD, Hui-Sun Leong, PhD, Tim CP Somervaille, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 178.
https://doi.org/10.1182/blood-2018-178
Published: 2018